Document is current
Any future updates will be listed below
-
Authors
Li, Yan
Du, Jiayuan
Wei, Lingjia
Tan, Tianmeng
Bao, Liyi
Su, Jinqiu
Wang, He
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82160443, 82160443, 82160443, 82160443, 82160443, 82160443, 82160443)
Guangxi Natural Science Foundation (2020GXNSFAA159023, 2020GXNSFAA159023, 2020GXNSFAA159023, 2020GXNSFAA159023, 2020GXNSFAA159023, 2020GXNSFAA159023, 2020GXNSFAA159023)
2021 Key Laboratory of Regional High-Incidence Tumor Early Prevention and Treatment Independent Research Project (GKE-ZZ 202147, GKE-ZZ 202147, GKE-ZZ 202147, GKE-ZZ 202147, GKE-ZZ 202147, GKE-ZZ 202147, GKE-ZZ 202147)
- License Information
-
More Information
Article History
Received: 30 November 2024
Accepted: 5 June 2025
First Online: 1 July 2025
Declarations
:
: The protocol for ethics approval is approved by [Medical Ethics Committee of Guangxi Medical University Cancer Hospital], in accordance with the Declaration of Helsinki and national regulations.
: Informed consent was obtained from all individual participants included in the study.
: The participants have consented to the submission of the case data for publication.
: The authors declare no competing interests.
